Avian Influenza (Bird Flu) in Chickens: Clinical Signs, Diagnosis, and Control

Introduction

Avian influenza (AI) is a highly contagious viral disease of domestic poultry caused by type A influenza viruses of the family Orthomyxoviridae. The virus is classified into low pathogenic (LPAI) and highly pathogenic (HPAI) forms based on its virulence in chickens. HPAI causes systemic infection with mortality rates approaching 100% in susceptible flocks, while LPAI typically produces mild respiratory or reproductive signs [1]. This article provides an exhaustive clinical and diagnostic reference for avian influenza in chickens, with particular attention to outbreaks in endemic regions such as Kerala, India, and emphasizes the differential diagnosis from other avian bacterial and viral pathogens.

Etiology and Biophysical Characteristics

Avian influenza virus (AIV) is an enveloped, single-stranded negative-sense RNA virus with a segmented genome comprising eight gene segments. Subtypes are defined by the surface glycoproteins hemagglutinin (HA; 16 subtypes, H1-H16) and neuraminidase (NA; 9 subtypes, N1-N9). The HA0 cleavage site sequence determines pathogenicity: HPAI viruses possess multiple basic amino acids at the cleavage site, allowing systemic replication, whereas LPAI viruses have a single basic residue and replicate only in respiratory and enteric epithelia [1, 2]. The viral envelope is derived from the host cell membrane and contains the M2 ion channel, essential for uncoating. The replication cycle involves attachment to sialic acid receptors (alpha-2,3-linked in avian species), entry via endocytosis, and pH-dependent fusion [1].

Epidemiology and Transmission

Avian influenza in chickens occurs globally, with seasonal peaks in temperate regions. Wild waterfowl serve as the natural reservoir for all AIV subtypes, and the virus spreads to domestic poultry via fecal-oral, respiratory, and fomite routes. LPAI viruses circulate endemically in many regions, while HPAI emerges from LPAI precursors after circulation in terrestrial poultry. Historically, H5N1, H5N8, and H7N9 have caused major epizootics [2]. In India, the state of Kerala has experienced repeated HPAI outbreaks, particularly in backyard and commercial layer flocks. These outbreaks are linked to migratory bird flyways and live bird market networks [1]. The epidemiology in Kerala is characterized by rapid spread due to high poultry density and limited biosecurity in smallholder systems.

Clinical Signs

Clinical manifestations depend on the pathogenicity of the infecting strain. LPAI infection often remains subclinical or produces mild respiratory signs such as sneezing, ocular discharge, and rales. Egg production drops and minor shell quality deterioration may occur. In contrast, HPAI presents with acute onset of severe depression, cyanosis of comb and wattles, edema of the head and neck, petechial hemorrhages on shanks, diarrhea, and sudden death. Neurologic signs including torticollis, ataxia, and opisthotonos are common [1, 2]. Morbidity and mortality can reach 100% within 48-72 hours in fully susceptible flocks. A summary table of clinical signs by pathotype is provided.

Table 1: Clinical Signs of Avian Influenza in Chickens by Pathotype

Pathology

Gross lesions in HPAI include severe subcutaneous edema, hemorrhages on the mucosal surfaces of the trachea, proventriculus, and gizzard, and petechiae on epicardial fat. The spleen and liver may be swollen and mottled. Pancreatic necrosis, typically with pale foci, is pathognomonic for HPAI caused by H5 and H7 subtypes [1]. LPAI lesions are limited to mild tracheitis, airsacculitis, and catarrhal exudates. Histologically, HPAI causes lymphocytic encephalitis, multifocal myocardial necrosis, and necrotizing pancreatitis. Viral antigen is detected by immunohistochemistry in endothelial cells, neurons, and parenchymal organs [2].

Diagnosis

Accurate diagnosis is essential for rapid containment. The World Organisation for Animal Health (WOAH) prescribes diagnostic protocols for both LPAI and HPAI.

Sample Collection and Handling

Appropriate samples include tracheal and cloacal swabs (placed in viral transport medium), fresh tissues (trachea, lung, spleen, brain, pancreas) from recently dead or euthanized birds, and sera for serological assays. Swabs from live birds should target the oropharynx and cloaca; combined swabs from the same bird are acceptable but should be kept separate by individual [1].

Laboratory Methods

Virus Isolation: Inoculation of specific pathogen free (SPF) embryonated chicken eggs via the allantoic route remains the gold standard. Allantoic fluid is harvested after 2-5 days and tested for hemagglutination activity. Subtype determination is performed using reference antisera or reverse transcription PCR (RT-PCR) [1].

Molecular Detection: Real time RT-PCR targeting the matrix gene is the primary screening tool due to its speed and sensitivity. Positive samples are further subtyped using H5, H7, and H9 specific assays. Pathogenicity confirmation requires sequencing of the HA cleavage site [1, 2]. Automated nucleic acid extraction and amplification platforms reduce turnaround time.

Serology: The hemagglutination inhibition (HI) test and enzyme linked immunosorbent assay (ELISA) detect antibodies against nucleoprotein or subtype specific HA. Serology is useful for surveillance in unvaccinated populations but cannot distinguish natural infection from vaccination unless DIVA (Differentiating Infected from Vaccinated Animals) strategies using sentinel birds or NS1 ELISA are employed [1].

Pathogenicity Testing: In ovo pathogenicity assay (intravenous pathogenicity index, IVPI) in 4-6 week old chickens classifies isolates: LPAI (IVPI < 1.2), HPAI (IVPI >= 1.2). Molecular analysis of the HA cleavage site is now accepted for direct pathogenicity classification without live animal testing [1].

The following Mermaid diagram summarizes the diagnostic workflow for suspected avian influenza in chickens.

flowchart TD
    A[Clinical suspicion: high morbidity/mortality, respiratory/nervous signs], > B[Collect tracheal and cloacal swabs in VTM]
    B, > C[Transport to reference laboratory under cold chain]
    C, > D{Initial screening}
    D, >|Pooled swabs| E[Matrix gene real-time RT-PCR]
    E, > F{Positive?}
    F, >|No| G[Report negative: exclude AI]
    F, >|Yes| H[Subtype-specific RT-PCR: H5, H7, H9]
    H, > I{Subtype confirmed?}
    I, >|H5 or H7| J[HA cleavage site sequencing]
    J, > K[Classify as LPAI or HPAI based on motif]
    I, >|Other subtypes| L[Further characterize if needed]
    K, > M[Notify WOAH and implement control measures]
    M, > N[Serological surveillance and epidemiologic investigation]

Differential Diagnosis

Several diseases produce clinical signs that overlap with avian influenza. Infectious Coryza in Poultry and Ducks (caused by Avibacterium paragallinarum) presents with facial edema and nasal discharge but lacks cyanosis and high mortality; its molecular detection by PCR helps differentiate it from AI. Fowl Cholera (Pasteurella multocida) causes acute septicemia with hemorrhages and high mortality, but Gram staining and culture reveal bipolar staining rods. Newcastle disease (velogenic) is clinically indistinguishable from HPAI, requiring laboratory confirmation by RT-PCR and embryonated egg inoculation. Other considerations include mycoplasmosis, avian encephalomyelitis, and toxicity [1, 2]. For detailed comparison, see the site's article on Infectious Coryza in Chickens: Drugs, Treatment Protocols, and Differential Diagnosis.

Control and Prevention

Control strategies depend on the pathogenicity and epidemiological context. For LPAI, containment and elimination of infected flocks combined with movement restrictions may suffice. For HPAI, stamping out protocols (humane depopulation of infected and contact flocks, quarantine, disinfection) are enforced by veterinary authorities in accordance with WOAH standards [1]. Stamping out remains the primary control method in disease free countries and during novel incursions.

Biosecurity Measures

Core biosecurity includes strict isolation of poultry from wild birds (netting, covered feed and water), disinfection of vehicles and equipment, all in/all out production, and visitor restrictions. Footbaths with appropriate disinfectants (phenolic compounds, aldehydes, or quaternary ammonium compounds at correct concentrations) are required. Surveillance of live bird markets and early detection systems are critical in endemic areas such as Kerala [1].

Vaccination

Vaccination is used as an adjunct to stamping out in some regions, either prophylactically or during outbreaks. Available vaccines include inactivated whole virus vaccines (bivalent or monovalent) and recombinant vector vaccines (e.g., fowlpox virus expressing H5 HA). Vaccination should be combined with a DIVA strategy for serological monitoring. However, vaccination does not prevent infection or shedding entirely and can mask clinical signs, necessitating robust molecular surveillance [1, 2]. The site provides an overview in Avian Influenza Vaccine: Types, Strategies, and Efficacy in Poultry.

Antiviral Therapy

Antiviral drugs such as neuraminidase inhibitors (oseltamivir, zanamivir) are not approved for use in poultry due to risk of resistance and lack of efficacy data in large flocks. Supportive care is not recommended in HPAI outbreaks due to the goal of rapid eradication [1].

Regional Perspective: Avian Influenza in Kerala

The southern Indian state of Kerala has experienced recurrent HPAI H5N1 outbreaks since the early 2000s, primarily affecting backyard free range chickens and occasionally commercial layers. The dense poultry population, proximity to wetlands hosting migratory waterfowl, and informal trade networks facilitate virus introduction and spread. Culling operations, movement bans, and compensation programs are routinely implemented. Zoonotic potential is recognized, but the focus here is on veterinary management. Further details are available in Avian Influenza in Chickens: Kerala Outbreaks and Zoonotic Potential on this portal. Ongoing surveillance using molecular detection and subtype differentiation is essential for early warning in this region.

Conclusion

Avian influenza remains one of the most economically devastating viral diseases of chickens. A clear understanding of its etiology, clinical presentations, and pathological hallmarks is essential for rapid clinical suspicion. Definitive diagnosis relies on molecular detection and sequence based pathogenicity classification. Control hinges on rigorous biosecurity, stamping out policies, and judicious vaccination where appropriate. Integration of laboratory confirmation with field epidemiology, particularly in high risk regions like Kerala, allows effective containment and reduction of viral spread.

References

[1] Swayne DE, Suarez DL, Sims LD. Influenza. In: Swayne DE, editor. Diseases of Poultry. 14th ed. Hoboken: Wiley-Blackwell; 2020. p. 210-256.

[2] World Organisation for Animal Health (WOAH). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 3.3.4: Avian influenza (infection with avian influenza viruses). Paris: WOAH; 2021. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.